The registration link will be activated at 10 am tomorrow, April 23. The last date to apply is May 2, 2026 and the last date for fee payment of registered candidates is May 4, 2026. The examination ...
India moved a step closer to ending its dependence on imported chip packaging technology on Sunday, with Odisha Chief Minister Mohan Majhi laying the foundation stone for the country’s first glass ...
LOS ANGELES, March 22 (Reuters) - SpaceX and Tesla (TSLA.O), opens new tab will build two advanced chip factories at a sprawling facility in Austin, Texas, one to power cars and humanoid robots, and ...
Many highly indebted advanced economies face a grim fiscal outlook. Under current policies, the public debt ratios of countries including Belgium, France, the United Kingdom, and the United States are ...
This is read by an automated voice. Please report any issues or inconsistencies here. L.A. Unified high school students enrollment in Advanced Placement courses and passing scores have showed marked ...
The United States military is the most powerful fighting force on the planet. Its spending outpaces every other nation by a wide margin, and the tools that American servicemembers have at their ...
Dr. Andrew Pieper, director of the Brain Health Medicines Center at University Hospitals and senior author of the study, emphasizes this represents a fundamental shift in understanding the disease.
A wireless electronic prosthesis implanted under the retina has been shown to restore central vision in people with an advanced form of dry age-related macular degeneration, leading to improvement in ...
Supernal sacked its C suite and its planned S-A2 tiltrotor air taxi in September. Credit: Supernal This has been a breakthrough year for the nascent advanced air mobility industry, as the leading ...
NEW YORK, Sept 16 (Reuters) - Japan's top power generator JERA is in advanced talks to buy natural gas production assets in the U.S. for around $1.7 billion, people familiar with the matter said, the ...
Cemiplimab plus chemotherapy doubled the 5-year survival rate compared to chemotherapy alone in advanced NSCLC patients. The EMPOWER-Lung 3 trial showed a median overall survival of 21.1 months with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results